Paul A. Rota, Stephanie L. Liffick, Jennifer S. Rota, Russell S. Katz,
Susan Redd, Mark Papania, and William J. Bellini
Abstract and Introduction
Abstract
From 1997 to 2001, sequence data from 55 clinical specimens were obtained
from confirmed measles cases in the United States, representing 21 outbreaks
and 34 sporadic cases. Sequence analysis indicated the presence of 11 of the
recognized genotypes. The most common genotypes detected were genotype D6,
usually identified from imported cases from Europe, and genotype D5,
associated with importations from Japan. A number of viruses belonging to
genotype D4 were imported from India and Pakistan. Overall, viral genotypes
were determined for 13 chains of transmission with an unknown source of virus,
and seven different genotypes were identified. Therefore, the diversity of
Measles virus genotypes observed in the United States from 1997 to 2001
reflected multiple imported sources of virus and indicated that no strain of
measles is endemic in the United States.
Introduction
An important component of laboratory surveillance for measles is the
genetic characterization of wild-type viruses.[1] This genetic
information provides a powerful adjunct to standard epidemiologic data for
describing the transmission pathways of Measles virus (MeV). Molecular
epidemiology supports classical epidemiology in cases for which the source of
imported MeV is known by confirming that the viral genotype obtained is
consistent with the genotype known to be circulating in the country or region
from which the case was imported. Molecular epidemiology fills in the gaps of
information when classical epidemiology fails to discover the source of MeV,
by providing a likely source on the basis of the genotypic information.
Monitoring the pattern of measles genotypes in an area can help document
the effectiveness of control measures. For example, in areas that have endemic
transmission of measles, virologic surveillance of cases detects a limited
number of genotypes. On the other hand, in areas where endemic transmission of
virus has been interrupted, a variety of genotypes are detected, reflecting
the multiple sources of imported viruses. Virologic surveillance has already
been used to help document the interruption of transmission of measles in the
United States[2-4] and Australia.[5] In addition,
genetic analysis of viruses provides a means to differentiate
vaccine-associated cases of measles from cases caused by infection with
wild-type virus. Current surveillance protocols call for the collection of
appropriate specimens for virologic surveillance during all phases of measles
control. For countries such as the United States that are in the elimination
phase of measles control, the goal is to collect a specimen for viral
isolation along with a serum sample at first contact with each suspected case.
Genetic characterization of wild-type MeV is based on sequence analysis of
two variable regions on the viral genome. The targets for molecular
epidemiologic studies are the 450 nucleotides coding for the 150 amino acids
comprising the COOH-terminus of the nucleoprotein and the entire
protein-coding region of the hemagglutinin gene. Based on these sequences, a
number of genotypes have been identified.[2,3,5-18] The World
Health Organization (WHO) recognizes 20 genotypes and one proposed genotype,[19-21]
including several new genotypes that have been identified in the last 3 years.[14,15,21-23]
The prototype (Edmonston) strain of measles as well as all the currently used
measles vaccines are in genotype A.[21]
The purpose of this report is to describe the genetic characteristics of
wild-type measles viruses isolated in the United States during 1997-2001.
Overall, the results show a pattern consistent with the continued interruption
of endemic transmission. Viruses representing several of the recently
described genotypes were associated with imported cases in the United States,
and this information has increased our understanding of the degree of genetic
diversity in wild-type measles viruses.
Section 1 of 4
Paul A. Rota, Stephanie L. Liffick, Jennifer S. Rota,
Russell S. Katz, Susan Redd, Mark Papania, and
William J. Bellini, Centers for Disease Control and Prevention,
Atlanta, Georgia, USA
Dr. Rota is a supervisory microbiologist in
the Measles Virus Section, Division of Viral and Rickettsial Diseases,
Centers for Disease Control and Prevention, in Atlanta. His research
interests include molecular epidemiology of viral diseases, development of
improved diagnostic techniques and vaccines for viral diseases,
pathogenesis of viral diseases, and zoonotic paramyxoviruses.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.
"A foolish faith in authority is the worst enemy of truth."
-- Albert Einstein, letter to a friend, 1901
"I know of no safe depository of the ultimate powers of the society but the people themselves, and if we think them not enlightened enough to exercise control with a wholesome discretion, the remedy is not to take it from them, but to inform their discretion by education."
-- Thomas Jefferson, letter to William C. Jarvis, September 28, 1820
"What's the point of vaccination if it doesn't protect you from the unvaccinated?"
-- Sandy Gottstein
"Who gets to decide what the greater good is and how many will be sacrificed to it?"